Correlation Between Trillium Therapeutics and Euronext
Can any of the company-specific risk be diversified away by investing in both Trillium Therapeutics and Euronext at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trillium Therapeutics and Euronext into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trillium Therapeutics and Euronext NV, you can compare the effects of market volatilities on Trillium Therapeutics and Euronext and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trillium Therapeutics with a short position of Euronext. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trillium Therapeutics and Euronext.
Diversification Opportunities for Trillium Therapeutics and Euronext
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Trillium and Euronext is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Trillium Therapeutics and Euronext NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Euronext NV and Trillium Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trillium Therapeutics are associated (or correlated) with Euronext. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Euronext NV has no effect on the direction of Trillium Therapeutics i.e., Trillium Therapeutics and Euronext go up and down completely randomly.
Pair Corralation between Trillium Therapeutics and Euronext
If you would invest 9,317 in Euronext NV on January 20, 2024 and sell it today you would earn a total of 103.00 from holding Euronext NV or generate 1.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Trillium Therapeutics vs. Euronext NV
Performance |
| Timeline |
| Trillium Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Euronext NV |
Trillium Therapeutics and Euronext Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Trillium Therapeutics and Euronext
The main advantage of trading using opposite Trillium Therapeutics and Euronext positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trillium Therapeutics position performs unexpectedly, Euronext can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Euronext will offset losses from the drop in Euronext's long position.| Trillium Therapeutics vs. Gulf Resources | Trillium Therapeutics vs. Albemarle Corp | Trillium Therapeutics vs. Microbot Medical | Trillium Therapeutics vs. Weyco Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |